Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Action of Epigenetic Modifiers in Cystic Fibrosis Treatment: ex Vivo Model of Nasal Epithelium of CF Patients

NCT01883284 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT01883284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01883284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Action of Epigenetic Modifiers in Cystic Fibrosis Treatment: ex Vivo Model of Nasal Epithelium of CF Patients
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
November 30, 2014
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, healthy subjects